Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
66 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

CLDI — Calidi Biotherapeutics, Inc. Dilution Risk Tracker

Track CLDI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLDI — Get alerts when the score changes →

As of October 13, 2026, Calidi Biotherapeutics, Inc. (CLDI) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Calidi Biotherapeutics, Inc. has a market capitalization of $2.45M, 2.58M shares outstanding, 29 institutional holders tracked. Stored dilution-related fields include 58.2K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊Float Risk—
⚠️ Warrant Exposure
15
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 65%
• 50-day avg $0.23 below $1 exchange minimum
• 8 months cash with weak price
🔁 Convertible Conversion model 60%
• Major convertible overhang: 67% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track CLDI — Get forecast alerts →

Market Data

Market Cap$2.45M
Shares Outstanding2.58M
FloatN/A
Cash$9.60M
Debt$645.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore66/100DilutionWatch score record
Shares Outstanding2.58MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$2.45MMarket data cache
Cash Runway7.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants58.2KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 354.2% shares (2026Q1 vs prior)
29 institutional holders · 2.04M shares
#1 ARMISTICE CAPITAL, LLC 879.0K shares
#2 SABBY MANAGEMENT, LLC 434.9K shares
#3 Warberg Asset Management LLC 250.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest233.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-03-27
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CLDI Dilution Snapshot

Calidi Biotherapeutics, Inc. (CLDI) has a DilutionScore of 66/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CLDI's DilutionScore is currently 66/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 60/100 (High risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202666/100HIGH6 days
Oct 01 – Oct 07, 202660/100HIGH7 days
Aug 22 – Sep 30, 202672/100HIGH40 days
Aug 14 – Aug 21, 202663/100HIGH7 days
Jul 16 – Aug 13, 202679/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CLDI shares outstanding have increased 112.5% from 7.17M (Mar 2026) to 15.23M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 12, 202615.23M10.72M▲ 1.22%
May 09, 202615.23M10.59M▲ 0.02%
Apr 07, 202610.90M10.58M▲ 7.45%
Apr 01, 20269.50M9.85M▲ 50.94%
Mar 17, 20267.17M6.53M▲ 5.53%
Mar 14, 20267.17M6.18M▼ 2.09%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CLDI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CLDI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CLDI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for CLDI
CLDI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.